C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 317/24 (2006.01) A61K 31/10 (2006.01) A61K 31/12 (2006.01) A61K 31/15 (2006.01) A61K 31/18 (2006.01) A61K 31/27 (2006.01) A61K 31/33 (2006.01) A61K 31/44 (2006.01) C07C 311/16 (2006.01) C07C 317/14 (2006.01) C07C 317/22 (2006.01) C07C 317/32 (2006.01) C07C 317/44 (2006.01) C07C 321/28 (2006.01) C07C 323/22 (2006.01) C07C 323/62 (2006.01) C07D 213/53 (2006.01) C07D 317/72 (2006.01) C07D 333/22 (2006.01) C07D 339/06 (2006.01)
Patent
CA 2250350
The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
L'invention concerne le nouveau composé de la formule (I), qui est utile pour le traitement des maladies associées à la cyclo-oxygénase-2. L'invention concerne, également, des compositions pharmaceutiques pour le traitement de maladies associées à la cyclo-oxygénase-2 contenant les composés de la formule (I).
Dube Daniel
Fortin Rejean
Frenette Richard
Friesen Richard
Guay Daniel
Merck Frosst Canada Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Bisarylcyclobutene derivates as cyclooxygenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bisarylcyclobutene derivates as cyclooxygenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisarylcyclobutene derivates as cyclooxygenase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1870707